Mon, December 16, 2019
Fri, December 13, 2019
Thu, December 12, 2019

Esther Rajavelu Initiated (ARWR) at Hold on, Dec 13th, 2019

-
Esther Rajavelu of Oppenheimer, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold on, Dec 13th, 2019.

Esther has made no other calls on ARWR in the last 4 months.



There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 1 agrees with Esther's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $50 on, Tuesday, November 19th, 2019


These are the ratings of the 3 analyists that currently disagree with Esther


  • Joel Beatty of "Baird" Upgraded from Hold to Buy and Increased Target to $70 on, Monday, November 25th, 2019
  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, November 13th, 2019
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $45 on, Tuesday, October 22nd, 2019
-